المؤلفون: Richier Q; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., De Valence B; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., Chopin D; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., Gras E; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France.; Sorbonne Université, IPLESP, Inserm UMR-S1136, Paris, France., Levi LI; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France.; Sorbonne Université, IPLESP, Inserm UMR-S1136, Paris, France., Abi Aad Y; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., Pacanowski J; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., Meynard JL; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., Plaçais L; Département de Médecine Interne et Immunologie clinique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Fey D; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France., Couture P; Service de Médecine Interne, Hôpital Foch, Suresnes, France., Martin-Blondel G; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.; INSERM UMR1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France.; Faculté de Médecine, Université de Toulouse Paul Sabatier, Toulouse, France., Pestre V; Service de médecine interne et maladies infectieuses, Centre hospitalier Avignon, Avignon, France., Woessner J; Service de médecine interne et maladies infectieuses, Centre hospitalier Avignon, Avignon, France., Ancellin S; Centre hospitalier d'Auch, France., Weyrich P; Unité d'Infectiologie, Groupement des Hôpitaux Catholiques de Lille, F-59160, Lille, France., Carpentier B; Unité d'Infectiologie, Groupement des Hôpitaux Catholiques de Lille, F-59160, Lille, France., Idri S; Etablissement Français du Sang, Créteil, France., Tiberghien P; Etablissement Français du Sang, La Plaine Saint-Denis, France.; UMR 1098 RIGHT Inserm Université de Franche-Comté, Etablissement Français du Sang, Besançon, France., Surgers L; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France.; Sorbonne Université, IPLESP, Inserm UMR-S1136, Paris, France., Hueso T; Service d'hématologie clinique, Hôpital Avicenne, APHP, Sorbonne Université Paris-Nord, Bobigny, France., Lacombe K; Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France.; Sorbonne Université, IPLESP, Inserm UMR-S1136, Paris, France.

المصدر: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Mar; Vol. 18 (3), pp. e13272.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/therapy, Humans ; COVID-19 Serotherapy ; SARS-CoV-2 ; Immunization, Passive ; Immunocompromised Host ; Antibodies, Viral/therapeutic use ; Antibodies, Neutralizing

SCR Organism: SARS-CoV-2 variants

المؤلفون: Chalouni M; Univ. Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000 Bordeaux, France., Pol S; Université de Paris, Assistance Publique - Hôpitaux de Paris Centre, Hôpital Cochin, Département d'Hépatologie, INSERM U-1223, Institut Pasteur, Paris, France.; Université de Paris, Paris, France., Sogni P; Université de Paris, Assistance Publique - Hôpitaux de Paris Centre, Hôpital Cochin, Département d'Hépatologie, INSERM U-1223, Institut Pasteur, Paris, France.; Université de Paris, Paris, France., Fontaine H; Université de Paris, Assistance Publique - Hôpitaux de Paris Centre, Hôpital Cochin, Département d'Hépatologie, INSERM U-1223, Institut Pasteur, Paris, France., Lacombe K; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.; APHP. Est, Hôpital Saint-Antoine, Service de Maladies Infectieuses et Tropicales, Paris, F75012, France., Lacombe JM; INSERM Transfert, Paris, France., Esterle L; Univ. Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000 Bordeaux, France., Dorival C; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, F75012, Paris, France., Bourlière M; Department of Hepatology and Gastroenterology, Hôpital Saint Joseph, Marseille, France., Bani-Sadr F; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Robert Debré Hospital, University Hospital, Reims, France., de Ledinghen V; Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépatologie, Bordeaux, France.; INSERM U1053, Université de Bordeaux, Bordeaux, France., Zucman D; Hôpital Foch, service de médecine interne, Suresnes, France., Larrey D; Service des maladies de l'appareil digestif, Hôpital Saint Eloi, IBR- Inserm, Montpellier, France., Salmon D; Université de Paris, Paris, France.; Service Maladies infectieuses et tropicales, AP-HP. Centre, Hôpital Cochin Hôtel Dieu, Paris, France., Carrat F; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.; AP-HP. Est, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France., Wittkop L; Univ. Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000 Bordeaux, France.; CHU de Bordeaux, Pôle de santé publique, F-33000 Bordeaux, France., Martinez V

مؤلفون مشاركون: ANRS CO13 HEPAVIH, ANRS CO22 HEPATHER Cohorts Study Groups

المصدر: HIV medicine [HIV Med] 2021 Nov; Vol. 22 (10), pp. 924-935. Date of Electronic Publication: 2021 Aug 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

مواضيع طبية MeSH: Coinfection*/drug therapy , HIV Infections*/complications , HIV Infections*/drug therapy , HIV Infections*/epidemiology , Hepatitis C*/complications , Hepatitis C*/drug therapy , Hepatitis C, Chronic*/complications , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/epidemiology , Neoplasms*/complications , Neoplasms*/epidemiology, Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Hepacivirus ; Humans ; Mediation Analysis ; Sustained Virologic Response

المؤلفون: Chalouni M; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France., Wittkop L; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.; Department of Public Health, CHU de Bordeaux, Bordeaux, France., Bani-Sadr F; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Robert Debré Hospital, University Hospital, Reims, France., Lacombe K; INSERM Pierre Louis Institute of Epidemiology and Public Health, IPLESP, Sorbonne University, Paris, France.; Infectious Diseases Department, Saint-Antoine Hospital, APHP, Paris, France., Esterle L; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France., Gilbert C; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France., Miailhes P; Department of Infectious and Tropical Diseases, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France., Zucman D; Internal Medicine Unit, Hôpital Foch, Suresnes, France., Valantin MA; Inserm, Department of Infectious Diseases, Pierre Louis Institute of Epidemiology and Public Health, Pitié-Salpêtrière Hospital, Sorbonne University, AP-HP, Paris, France., Brégigeon-Ronot S; Clinical Immunohematology Department, Marseille Public University Hospital System (AP-HM), Sainte-Marguerite Hospital, Aix-Marseille University, Marseille, France., Morlat P; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.; Department of Internal Medicine and Infectious Diseases, Saint André Hospital, Bordeaux University Hospital, Bordeaux, France., Billaud E; Infectious Disease Unit, CHU Nantes, CIC 1413 INSERM, COREVIH, Pays de la Loire, Nantes, France., Piroth L; Infectious Diseases Department, Dijon University Hospital, Dijon, France.; University of Bourgogne-Franche-Comté, Dijon, France., Naqvi A; Infectious Diseases Department, Nice University Hospital, Archet Hospital, Nice, France., Sogni P; Hepatology Department, APHP, Cochin Hospital, INSERM U-1223 and ICD, Pasteur Institute, Paris University, Paris, France.; Paris University, Paris, France., Salmon D; Paris University, Paris, France.; Infectious and Tropical Diseases Department, AP-HP Centre, Cochin Hospital, Hôtel Dieu, Paris, France.

مؤلفون مشاركون: ANRS CO13 HEPAVIH Cohort Study Group

المصدر: HIV medicine [HIV Med] 2021 Oct; Vol. 22 (9), pp. 791-804. Date of Electronic Publication: 2021 Jul 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

مواضيع طبية MeSH: Coinfection*/complications , Coinfection*/drug therapy , HIV Infections*/complications , HIV Infections*/drug therapy , HIV Infections*/epidemiology , Hepatitis C*/complications , Hepatitis C*/drug therapy , Hepatitis C*/epidemiology , Hepatitis C, Chronic*/complications , Hepatitis C, Chronic*/drug therapy, Antiviral Agents/therapeutic use ; Hepacivirus ; Humans ; Liver Cirrhosis/epidemiology ; Prospective Studies ; Treatment Outcome

المؤلفون: Rosenthal E; Internal Medicine Department, CHU de Nice, Hôpital Archet 1, Nice, France., Fougerou-Leurent C; Pharmacology Department, CHU Rennes, Rennes, France.; Inserm, CIC1414, Rennes, France., Renault A; Inserm, CIC1414, Rennes, France.; Pharmacology Laboratory, Faculté de Médecine, Univ Rennes 1, Rennes, France., Carrieri MP; Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Inserm, IRD, Aix Marseille Univ, Marseille, France.; Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France., Marcellin F; Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Inserm, IRD, Aix Marseille Univ, Marseille, France.; Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France., Garraffo R; Clinical Pharmacology and Toxicology Department, CHU de Nice, Nice, France., Teicher E; Infectious Diseases Department, APHP, Hôpital Bicêtre, Le Kremlin Bicêtre, France., Aumaitre H; Infectious and Tropical Diseases Department, Hôpital de Perpignan, Perpignan, France., Lacombe K; Infectious Diseases Department, APHP, Hôpital Saint Antoine, Paris, France., Bailly F; Hepatology Department, HCL, Hôpital de la Croix-Rousse, Lyon, France., Billaud E; Infectious Diseases Department, CHU Nantes, Nantes, France., Chevaliez S; Virology Department, APHP, Hôpital Henri Mondor, Créteil, France., Dominguez S; Clinical Immunology Department, APHP, Hôpital Henri Mondor, Créteil, France., Valantin MA; Infectious Diseases Department, APHP, Hôpital La Pitié Salpêtrière, Paris, France., Reynes J; Infectious Diseases Department, CHU Montpellier, Montpellier, France., Naqvi A; Infectious Diseases Department, CHU de Nice, Hôpital Archet 1, Nice, France., Cotte L; Infectious Diseases Department, HCL, Hôpital de la Croix-Rousse, Lyon, France., Metivier S; Hepatogastroenterology Department, CHU Toulouse, Toulouse, France., Leroy V; Hepatogastroenterology Department, CHU Grenoble, Grenoble, France., Dupon M; Infectious Diseases Department, CHU Bordeaux, Bordeaux, France., Allegre T; Hemato Oncology Department, CH du Pays d'Aix, Aix-en-Provence, France., De Truchis P; Infectious Diseases Department, APHP, Hôpital R Poincaré, Garches, France., Jeantils V; Infectious Diseases Department, APHP, Hôpital J Verdier, Bondy, France., Chas J; Infectious and Tropical Diseases Department, APHP, Hôpital Tenon, Paris, France., Salmon-Ceron D; Infectious Diseases Department, APHP, Hôpital Cochin, Paris, France., Morlat P; Internal Medicine and Infectious Diseases Department, CHU Bordeaux, Bordeaux, France., Neau D; Infectious and Tropical Diseases Department, CHU Bordeaux, Bordeaux, France., Perré P; Internal Medicine Department, CHD Vendée, La Roche sur Yon, France., Piroth L; Infectious Diseases Department, CHU Dijon, Dijon, France., Pol S; Hepato-Gastroenterology Department, APHP, Hôpital Cochin, Paris, France., Bourlière M; Hepatogastroenterology Department, Hôpital Saint Joseph, Marseille, France., Pageaux GP; Hepatogastroenterology Department, CHU Montpellier, Montpellier, France., Alric L; Internal Medicine Department, CHU Toulouse, Toulouse, France., Zucman D; Internal Medicine Department, Hôpital Foch, Suresne, France., Girard PM; Infectious Diseases Department, APHP, Hôpital Saint Antoine, Paris, France., Poizot-Martin I; Immuno and Clinical Hematology department, APHM Sainte-Marguerite, Aix Marseille Univ, Marseille, France.; Inserm U912 (SESSTIM), Marseille, France., Yazdanpanah Y; Infectious and Tropical Diseases Department, APHP, Hôpital Bichat, Paris, France., Raffi F; Infectious Diseases Department, CHU Nantes, Nantes, France., Pabic EL; Pharmacology Department, CHU Rennes, Rennes, France.; Inserm, CIC1414, Rennes, France., Tual C; Pharmacology Department, CHU Rennes, Rennes, France.; Inserm, CIC1414, Rennes, France., Pailhé A; Unité de Recherche Clinique et Fondamentale sur les Hépatites Virales, ANRS (France Recherche Nord & Sud Sida-hiv Hépatites), Paris, France., Amri I; Unité de Recherche Clinique et Fondamentale sur les Hépatites Virales, ANRS (France Recherche Nord & Sud Sida-hiv Hépatites), Paris, France., Bellissant E; Pharmacology Department, CHU Rennes, Rennes, France.; Inserm, CIC1414, Rennes, France.; Pharmacology Laboratory, Faculté de Médecine, Univ Rennes 1, Rennes, France., Molina JM; Hepatogastroenterology Department, APHP, Hôpital Saint Louis, Paris, France.

مؤلفون مشاركون: ANRS HC31 SOFTRIH Study Group

المصدر: HIV medicine [HIV Med] 2018 Mar; Vol. 19 (3), pp. 227-237. Date of Electronic Publication: 2017 Dec 07.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

مواضيع طبية MeSH: Patient Reported Outcome Measures*, Benzimidazoles/*administration & dosage , Coinfection/*drug therapy , Fluorenes/*administration & dosage , HIV Infections/*drug therapy , Hepatitis C, Chronic/*drug therapy , Sofosbuvir/*administration & dosage, Aged ; Benzimidazoles/adverse effects ; Drug Administration Schedule ; Female ; Fibrosis ; Fluorenes/adverse effects ; Genotype ; HIV Protease Inhibitors/therapeutic use ; HIV-1/genetics ; Hepacivirus/genetics ; Hepatitis C, Chronic/pathology ; Humans ; Male ; Middle Aged ; Pilot Projects ; Sofosbuvir/adverse effects ; Sustained Virologic Response ; Treatment Outcome

المؤلفون: Michel L; Inserm U1178, Paris, France. laurent.michel@croix-rouge.fr.; UMRS1178, Paris-Sud University and Paris Descartes University, Paris, France. laurent.michel@croix-rouge.fr.; Centre Pierre Nicole, French Red Cross, Paris, France. laurent.michel@croix-rouge.fr., Lions C; Inserm U912 (SESSTIM), Marseille, France.; IRD, UMR-S912, Aix Marseille University, Marseille, France.; Regional Center for Disease Control Provence Alpes Côte d'Azur, Marseille, France., Winnock M; Inserm U897, Bordeaux, France., Lang JP; CHRU Strasbourg, Strasbourg, France., Loko MA; Inserm U897, Bordeaux, France., Rosenthal E; Hôpital l'Archet, Nice, France., Marchou B; Hôpital Purpan, Toulouse, France., Valantin MA; Groupe Hospitalier La Pitié Salpêtrière, Paris, France., Morlat P; Hôpital Saint-André, Bordeaux, France., Roux P; Inserm U912 (SESSTIM), Marseille, France.; IRD, UMR-S912, Aix Marseille University, Marseille, France.; Regional Center for Disease Control Provence Alpes Côte d'Azur, Marseille, France., Sogni P; Hôpital Cochin, Paris, France., Spire B; Inserm U912 (SESSTIM), Marseille, France.; IRD, UMR-S912, Aix Marseille University, Marseille, France.; Regional Center for Disease Control Provence Alpes Côte d'Azur, Marseille, France., Poizot-Martin I; Hôpital Sainte-Marguerite, Marseille, France., Lacombe K; Hôpital Saint-Antoine, Paris, France., Lascoux-Combe C; Hôpital Saint-Louis, Paris, France., Duvivier C; Hôpital Necker, Paris, France., Neau D; Hôpital Pellegrin, Bordeaux, France., Dabis F; Inserm U897, Bordeaux, France., Salmon-Ceron D; Hôpital Cochin, Paris, France., Carrieri MP; Inserm U912 (SESSTIM), Marseille, France.; IRD, UMR-S912, Aix Marseille University, Marseille, France.; Regional Center for Disease Control Provence Alpes Côte d'Azur, Marseille, France.

مؤلفون مشاركون: ANRS HEPAVIH CO13 study group

المصدر: HIV medicine [HIV Med] 2016 Nov; Vol. 17 (10), pp. 758-765.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

مواضيع طبية MeSH: Coinfection/*complications , HIV Infections/*complications , Hepatitis C, Chronic/*complications , Mental Disorders/*epidemiology , Substance-Related Disorders/*epidemiology, Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Female ; France/epidemiology ; Humans ; Male ; Middle Aged ; Prevalence ; Young Adult

المؤلفون: Mussini C; University of Modena and Reggio Emilia, Modena, Italy., Antinori A; National Institute for Infectious Disease 'L. Spallanzani', Rome, Italy., Bhagani S; University College London, London, UK., Branco T; Department of Infectious Diseases, Hospital Center, Lisbon, Portugal., Brostrom M; UNAIDS, Geneva, Switzerland., Dedes N; EATG, Athens, Greece., Bereczky T; EATG, Budapest, Hungary., Girardi E; National Institute for Infectious Disease 'L. Spallanzani', Rome, Italy., Gökengin D; Ege University, Izmir, Turkey., Horban A; Warsaw Medical University and Hospital of Infectious Diseases, Warsaw, Poland., Lacombe K; St Antoine Hospital, Paris, France., Lundgren JD; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Mendao L; EATG, Lisbon, Portugal., Mocroft A; University College London, London, UK., Oprea C; Victor Babes Hospital, Bucharest, Romania., Porter K; University College London, London, UK., Podlekareva D; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Battegay M; University Hospital of Basel, Basel, Switzerland., d'Arminio Monforte A; University of Milan, Milan, Italy.

مؤلفون مشاركون: European Aids Clinical Society

المصدر: HIV medicine [HIV Med] 2016 Jun; Vol. 17 (6), pp. 445-52. Date of Electronic Publication: 2015 Oct 22.

نوع المنشور: Clinical Conference; Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

مواضيع طبية MeSH: Standard of Care*, AIDS-Related Opportunistic Infections/*epidemiology , AIDS-Related Opportunistic Infections/*prevention & control , Coinfection/*epidemiology , Coinfection/*prevention & control , HIV Infections/*complications, AIDS-Related Opportunistic Infections/diagnosis ; AIDS-Related Opportunistic Infections/therapy ; Coinfection/diagnosis ; Coinfection/therapy ; Communicable Disease Control/methods ; Communicable Disease Control/organization & administration ; Europe ; Global Health ; Humans ; Societies, Scientific